About Luminas
Luminas is a Healthcare company based in Irvine (United States) founded in 2016. Developer of pain relief patches. Its chief executive, as recorded, is Matt Case. Its website luminas.com draws about 17 thousand monthly visits. Luminas offers products and services including Relief Patches, Sleep Patches, and Immune Patches. Its focus areas include Life Sciences, Drug Delivery and Patches. Its legal entity is LUMINAS Energy LLC. Similar companies include Valeritas, scPharmaceuticals and VeraDermics; 3 of its 3 listed similar companies have raised funding.
Company details
Luminas is involved in developing pain relief patches. They have developed a proprietary technology which allows capturing these electric field signatures from various natural remedies to reduce pain and inflammation. The product is FDA approved.
- Headquarters Irvine, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website luminas.com
- Social LinkedIn X Facebook Instagram
- Legal Name Luminas Energy Llc
Products & Services of Luminas
Luminas offers a comprehensive portfolio of products and services, including Relief Patches, Sleep Patches, and Immune Patches.
Natural patches that reduce pain and inflammation without chemicals.
Patches to promote faster sleep and longer rest without side effects.
Patches designed to enhance immune response naturally.
People of Luminas
2 people are tracked at Luminas (2 in leadership).
| Name | Role | Group |
|---|---|---|
Matt Case | CEO | Leadership |
Taylor Distler | Chief Operating Officer | Leadership |
Complete people profiles for Luminas
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Luminas
Luminas has 3 listed similar companies in our database, 3 of them funded. They include Valeritas, scPharmaceuticals and VeraDermics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| valeritas.com | 2003 | Bridgewater, United States | $181.36M | 141 | Wearable insulin patch pumps are developed for transdermal delivery. | |
| scpharmaceuticals.com | 2013 | Lexington, United States | $78.75M | 96 | Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure | |
| veradermics.com | 2020 | San Antonio, United States | $262.71M | Drug-delivery platforms for pediatric wart treatments are developed. |
Detailed similar companies of Luminas
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Luminas
The website of Luminas (luminas.com) receives about 16.5K visits a month.
- Monthly visits16.5K
▲ 2.5% vs previous month
Websites whose visitors overlap most with Luminas. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| patchmd.com | 100% | #912,833 | View details | ||
| inspiresleep.com | 70% | 542.4K | #96,087 | View details | |
quviviq.com | quviviq.com | 48% | #869,122 | – | |
zzzquil.com | zzzquil.com | 35% | #369,692 | – | |
| sleepdoctor.com | 35% | 680K | #98,870 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Luminas
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Luminas (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Luminas
Complete news archive for Luminas
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Luminas
Luminas was founded in 2016.
Luminas is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Matt Case is the CEO of Luminas, as recorded in our data.
Luminas is involved in developing pain relief patches. They have developed a proprietary technology which allows capturing these electric field signatures from various natural remedies to reduce pain and inflammation. The product is FDA approved.
Luminas's top competitors include scPharmaceuticals, VeraDermics and Valeritas.
Luminas offers Relief Patches, Sleep Patches, and Immune Patches.
Luminas operates through Luminas Energy Llc.